![Poster](/sites/default/files/assets/paragraphs/image/image/FB_940x788_Genetalks-ADR-Prince-George-Feb-1-2018.jpg)
Genomics may hold the key to preventing adverse drug reactions, through a field of study also known as pharmacogenomics.
Hear from three different perspectives: Colin Ross (Professor, Department of Pharmaceutical Sciences at UBC), Derek Desrosiers (Director, Pharmacy Practice Support at the BC Pharmacy Association) and Amani Saini (President and Founder, Adverse Drug Reaction Canada)
A question and answer period will follow the talk.